Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 May;72(2):303–308.

Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

L Matera 1, R Foa 1, F Malavasi 1, G Bellone 1, A Funaro 1, F Veglia 1, D Santoli 1
PMCID: PMC1541532  PMID: 3261664

Abstract

Freshly isolated B cells from chronic lymphocytic leukaemia patients (B-CLL) have been previously shown to induce a strong proliferative response and high levels of NK-like activity in lymphocytes from healthy donors. The present paper deals with the origin, mitotic state, target spectrum and cell surface phenotype of the NK-like effectors generated after stimulation with B-CLL. Experiments using large granular lymphocytes (LGL) and T cells as responders demonstrated that most of the precursors of the newly generated NK-like effectors express the CD3 antigen. The induction of NK-like activity paralleled cell activation, as judged by blast transformation, thymidine uptake and appearance of cell surface activation markers. The newly generated NK-like effectors displayed a T cell phenotype and a broader target repertoire than native NK cells.

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol. 1982 Oct;129(4):1758–1761. [PubMed] [Google Scholar]
  2. Brooks C. G. Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes. Nature. 1983 Sep 8;305(5930):155–158. doi: 10.1038/305155a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burns G. F., Triglia T., Werkmeister J. A. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells. J Immunol. 1984 Sep;133(3):1656–1663. [PubMed] [Google Scholar]
  4. Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982 Jun 1;155(6):1823–1841. doi: 10.1084/jem.155.6.1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grimm E. A., Ramsey K. M., Mazumder A., Wilson D. J., Djeu J. Y., Rosenberg S. A. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med. 1983 Mar 1;157(3):884–897. doi: 10.1084/jem.157.3.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kay H. D., Horwitz D. A. Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest. 1980 Oct;66(4):847–851. doi: 10.1172/JCI109923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
  8. London L., Perussia B., Trinchieri G. Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens. J Immunol. 1985 Feb;134(2):718–727. [PubMed] [Google Scholar]
  9. López-Botet M., Silva A., Rodríguez J., de Landazuri M. O. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression. J Immunol. 1982 Sep;129(3):1109–1115. [PubMed] [Google Scholar]
  10. Malavasi F., Bellone G., Matera L., Milanese C., Ferrero E., Funaro A., Demaria S., Caligaris-Cappio F., Camussi G., Dellabona P. Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro. Hum Immunol. 1985 Oct;14(2):87–102. doi: 10.1016/0198-8859(85)90067-9. [DOI] [PubMed] [Google Scholar]
  11. Matera L., Cardoso E., Caudana L., Moore M. Generation of non MHC restricted killing in non-cytotoxic T-lymphocytes from leukaemia patients. Br J Haematol. 1987 Feb;65(2):151–157. doi: 10.1111/j.1365-2141.1987.tb02257.x. [DOI] [PubMed] [Google Scholar]
  12. Matera L., Santoli D., Garbarino G., Pegoraro L., Bellone G., Pagliardi G. Modulation of in vitro myelopoiesis by LGL: different effects on early and late progenitor cells. J Immunol. 1986 Feb 15;136(4):1260–1265. [PubMed] [Google Scholar]
  13. Nieminen P., Saksela E. A shared antigenic specificity of human large granular lymphocytes and precursors of NK-like and allospecific cytotoxic effector cells. J Immunol. 1984 Aug;133(2):702–708. [PubMed] [Google Scholar]
  14. Ortaldo J. R., Bonnard G. D., Kind P. D., Herberman R. B. Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. J Immunol. 1979 Apr;122(4):1489–1494. [PubMed] [Google Scholar]
  15. Pattengale P. K., Gidlund M., Nilsson K., Sundström C., Sällström J., Simonsson B., Wigzell H. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells. Int J Cancer. 1982 Jan 15;29(1):1–7. doi: 10.1002/ijc.2910290102. [DOI] [PubMed] [Google Scholar]
  16. Perussia B., Starr S., Abraham S., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol. 1983 May;130(5):2133–2141. [PubMed] [Google Scholar]
  17. Phillips J. H., Lanier L. L. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562. J Exp Med. 1985 Jun 1;161(6):1464–1482. doi: 10.1084/jem.161.6.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Phillips J. H., Le A. M., Lanier L. L. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med. 1984 Apr 1;159(4):993–1008. doi: 10.1084/jem.159.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Poros A., Klein E. Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes. Cell Immunol. 1979 Aug;46(1):57–68. doi: 10.1016/0008-8749(79)90245-4. [DOI] [PubMed] [Google Scholar]
  20. Rimm I. J., Schlossman S. F., Reinherz E. L. Natural killer-like activity mediated by activated T lymphocytes. Cell Immunol. 1984 Sep;87(2):327–339. doi: 10.1016/0008-8749(84)90002-9. [DOI] [PubMed] [Google Scholar]
  21. Ritz J., Campen T. J., Schmidt R. E., Royer H. D., Hercend T., Hussey R. E., Reinherz E. L. Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science. 1985 Jun 28;228(4707):1540–1543. doi: 10.1126/science.2409597. [DOI] [PubMed] [Google Scholar]
  22. Santoli D., Francis M. K., Matera L., Ferrero D. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes. J Immunol. 1983 Aug;131(2):736–742. [PubMed] [Google Scholar]
  23. Santoli D., Francis M. K., Matera L. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability. Nat Immun Cell Growth Regul. 1985;4(2):103–112. [PubMed] [Google Scholar]
  24. Seeley J. K., Masucci G., Poros A., Klein E., Golub S. H. Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. J Immunol. 1979 Sep;123(3):1303–1311. [PubMed] [Google Scholar]
  25. Strassmann G., Bach F. H., Zarling J. M. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures. J Immunol. 1983 Apr;130(4):1556–1560. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES